1. Home
  2. FVRR vs ABCL Comparison

FVRR vs ABCL Comparison

Compare FVRR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

N/A

Current Price

$8.76

Market Cap

332.5M

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$12.70

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FVRR
ABCL
Founded
2010
2012
Country
Israel
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.5M
3.5B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
FVRR
ABCL
Price
$8.76
$12.70
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$18.43
$8.40
AVG Volume (30 Days)
434.8K
4.6M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
$21.85
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
160.56
52 Week Low
$8.61
$2.75
52 Week High
$28.00
$12.58

Technical Indicators

Market Signals
Indicator
FVRR
ABCL
Relative Strength Index (RSI) 44.28 58.33
Support Level $8.73 $10.44
Resistance Level $11.43 $12.58
Average True Range (ATR) 0.28 0.61
MACD 0.02 -0.21
Stochastic Oscillator 25.88 46.24

Price Performance

Historical Comparison
FVRR
ABCL

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: